tradingkey.logo
tradingkey.logo
Search

ATAI Life Sciences NV

ATAI
Add to Watchlist
7.180USD
0.0000.00%
Close 07-31 16:00ETQuotes delayed by 15 min
2.66BMarket Cap
LossP/E TTM

Shareholding Stats

Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Apeiron Investment Group Ltd
15.00%
Vanguard Capital Management, LLC
3.19%
Feilding-Mellen (Cosmo)
2.08%
Adage Capital Management, L.P.
1.92%
UBS Financial Services, Inc.
1.58%
Other
76.23%
Shareholders
Shareholders
Proportion
Apeiron Investment Group Ltd
15.00%
Vanguard Capital Management, LLC
3.19%
Feilding-Mellen (Cosmo)
2.08%
Adage Capital Management, L.P.
1.92%
UBS Financial Services, Inc.
1.58%
Other
76.23%
Shareholder Types
Shareholders
Proportion
Family Office
15.07%
Investment Advisor
9.87%
Hedge Fund
6.24%
Investment Advisor/Hedge Fund
4.50%
Individual Investor
3.80%
Research Firm
1.23%
Private Equity
0.76%
Bank and Trust
0.55%
Endowment Fund
0.20%
Other
57.78%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
296
73.07M
19.93%
+23.43M
2025Q4
218
45.07M
10.88%
+16.45K
2025Q3
249
45.57M
19.55%
+12.66M
2025Q2
225
29.96M
14.58%
+6.94M
2025Q1
223
23.03M
12.83%
-2.41M
2024Q4
236
15.60M
13.86%
+2.09M
2024Q3
236
13.53M
16.71%
-545.79K
2024Q2
246
14.10M
16.43%
-259.20K
2024Q1
244
14.41M
17.26%
-14.24M
2023Q4
251
15.93M
17.75%
-1.57M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Apeiron Investment Group Ltd
55.21M
15.14%
+14.20K
+0.03%
Oct 20, 2025
Feilding-Mellen (Cosmo)
7.66M
2.1%
-39.59K
-0.51%
Jan 02, 2026
Adage Capital Management, L.P.
7.08M
1.94%
+1.65M
+30.27%
Dec 31, 2025
Brand (Florian Olaf)
5.04M
1.38%
-250.00K
-4.73%
Sep 15, 2025
Deep Track Capital LP
4.68M
1.28%
+4.68M
--
Dec 31, 2025
Candriam Luxembourg S.A.
3.09M
0.85%
--
--
Feb 28, 2026
Morgan Stanley Investment Management Inc. (US)
2.87M
0.79%
-360.10K
-11.13%
Dec 31, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
AdvisorShares Psychedelics ETF
17.55%
ARK Genomic Revolution ETF
1.6%
Invesco NASDAQ Future Gen 200 ETF
0.69%
Even Herd Long Short ETF
0.14%
Avantis US Small Cap Equity ETF
0.08%
First Trust IPOX Europe Equity Opportunities ETF
0.06%
SPDR S&P International Small Cap ETF
0.05%
Fidelity Nasdaq Composite Index ETF
0%
ProShares Ultra Nasdaq Biotechnology
0%
Avantis US Equity ETF
0%
View more
AdvisorShares Psychedelics ETF
Proportion17.55%
ARK Genomic Revolution ETF
Proportion1.6%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.69%
Even Herd Long Short ETF
Proportion0.14%
Avantis US Small Cap Equity ETF
Proportion0.08%
First Trust IPOX Europe Equity Opportunities ETF
Proportion0.06%
SPDR S&P International Small Cap ETF
Proportion0.05%
Fidelity Nasdaq Composite Index ETF
Proportion0%
ProShares Ultra Nasdaq Biotechnology
Proportion0%
Avantis US Equity ETF
Proportion0%
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.